Key facts
- Ruihe Health’s last known valuation is $3.6M (Apr 2026).
- It has raised $580K; the latest was Early Stage VC ($580K) in Apr 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Ruihe Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruihe Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruihe Health
Developer of an AI-powered healthcare platform designed to prevent chronic diseases through predictive and personalized medical technology. The company offers advanced risk prediction, personalized intervention generation, causal inference for outcome validation, and standardized settlement reporting, enabling hospitals, insurers, and corporate health managers to quantify prevention effectiveness and integrate it into healthcare payment systems.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2025
- Website
- rehealth-ai.com/
- Ownership
- Privately Held (backing)
Ruihe Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruihe Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruihe Health in its N-PORT filings yet. We sweep new filings monthly.